Literature for peptidase M28.010: glutamate carboxypeptidase II

(References are filtered for relevance to Localization. To remove the filter click here. See explanation.)

2018
1. Endepols,H., Mottaghy,F.M., Simsekyilmaz,S., Bucerius,J., Vogt,F., Winz,O., Richarz,R., Krapf,P., Neumaier,B., Zlatopolskiy,B.D. and Morgenroth,A.
   In vivo molecular imaging of glutamate carboxypeptidase II expression in re-endothelialisation after percutaneous balloon denudation in a rat model
   Sci Rep8, 7411-7411. PubMed  Europe PubMed DOI  L
2016
2. Dannoon,S., Ganguly,T., Cahaya,H., Geruntho,J.J., Galliher,M.S., Beyer,S.K., Choy,C.J., Hopkins,M.R., Regan,M., Blecha,J.E., Skultetyova,L., Drake,C.R., Jivan,S., Barinka,C., Jones,E.F., Berkman,C.E. and Vanbrocklin,H.F.
   Structure-activity relationship of (18)F-labeled phosphoramidate peptidomimetic prostate-specific membrane antigen (PSMA)-targeted inhibitor analogues for PET imaging of prostate cancer
   J Med Chem59, 5684-5694. PubMed  Europe PubMed DOI  L
3. Derlin,T., Thiele,J., Weiberg,D., Thackeray,J.T., Puschel,K., Wester,H.J., Aguirre Davila,L., Larena-Avellaneda,A., Daum,G., Bengel,F.M. and Schumacher,U.
   Evaluation of 68Ga-glutamate carboxypeptidase II ligand positron emission tomography for clinical molecular imaging of atherosclerotic plaque neovascularization
   Arterioscler Thromb Vasc Biol36, 2213-2219. PubMed  Europe PubMed DOI  L
2015
4. Herrmann,K., Bluemel,C., Weineisen,M., Schottelius,M., Wester,H.J., Czernin,J., Eberlein,U., Beykan,S., Lapa,C., Riedmiller,H., Krebs,M., Kropf,S., Schirbel,A., Buck,A.K. and Lassmann,M.
   Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy
   J Nucl Med56, 855-861. PubMed  Europe PubMed DOI  L
2012
5. Schafer,M., Bauder-Wust,U., Leotta,K., Zoller,F., Mier,W., Haberkorn,U., Eisenhut,M. and Eder,M.
   A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer
   EJNMMI Res2, 23-23. PubMed  Europe PubMed DOI  L  I
2009
6. Hillier,S.M., Maresca,K.P., Femia,F.J., Marquis,J.C., Foss,C.A., Nguyen,N., Zimmerman,C.N., Barrett,J.A., Eckelman,W.C., Pomper,M.G., Joyal,J.L. and Babich,J.W.
   Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer
   Cancer Res69, 6932-6940. PubMed  Europe PubMed DOI  L
2003
7. Smith-Jones,P.M., Vallabhajosula,S., Navarro,V., Bastidas,D., Goldsmith,S.J. and Bander,N.H.
   Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor
   J Nucl Med44, 610-617. PubMed  Europe PubMed  L
2002
8. Freeman,L.M., Krynyckyi,B.R., Li,Y., Korupulu,G., Saleemi,K., Haseman,M.K. and Kahn,D.
   The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancer
   Q J Nucl Med46, 131-137. PubMed  Europe PubMed  L
9. Yao,D., Trabulsi,E.J., Kostakoglu,L., Vallabhajosula,S., Joyce,M.A., Nanus,D.M., Milowsky,M., Liu,H. and Goldsmith,S.J.
   The utility of monoclonal antibodies in the imaging of prostate cancer
   Semin Urol Oncol20, 211-218. PubMed  Europe PubMed DOI  L